Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Compliance of patients and physicians: experience and lessons from tuberculosis-II.
1983
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Long-term relapses after 12-month treatment forMycobacterium kansasiilung disease
2008
Treatment of pulmonary disease caused by Mycobacterium kansasii: Results of 18 vs 12 months' chemotherapy
1995
Mycobacterium xenopi infection and aspergilloma
1988
Synergistic effects of antimycobacterial drag combinations onMycobacterium avium complex determined radiometrically in liquid medium
1987
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
The Tuberculin Skin Test
1993 Standout
Risk Factors for Chronic Obstructive Pulmonary Disease Mortality in Chinese Adults
2008
The Effects of Refeeding on Peripheral and Respiratory Muscle Function in Malnourished Chronic Obstructive Pulmonary Disease Patients
1990
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Physiologic Effects of Oral Supplemental Feeding in Malnourished Patients with Chronic Obstructive Pulmonary Disease: A Randomized Control Study
1992
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria
1994
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
2008
Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection
1988
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment
2003
Mitogen-activated protein kinase pathways
1997 Standout
Increasing Incidence of Mycobacterium xenopi at Bellevue Hospital
2000
ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation
2006 Standout
The Effect of Supplementary Oral Nutrition in Poorly Nourished Patients with Chronic Obstructive Pulmonary Disease
1988
Exercise Training and Nutritional Supplementation for Physical Frailty in Very Elderly People
1994 Standout
Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease
1991
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Respiratory muscle function in patients with chronic obstructive pulmonary disease
1996
Late Relapse of Desquamative Interstitial Pneumonia
1987
Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease
2005
Nutritional support of the hospitalized patient
1997
Epidemiology and Clinical Significance of Nontuberculous Mycobacteria in Patients Negative for Human Immunodeficiency Virus in Switzerland
1992
Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary Rehabilitation
1993
Cancer-associated cachexia
2018 Standout
Resurgence of tuberculosis in children
1992 Standout
Evidence that Antituberculosis Drugs Are Really Effective in the Treatment of Pulmonary Infection Caused by Mycobacterium avium Complex
1988
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
Clarithromycin in the Treatment of Mycobacterium avium Lung Infections in Patients Without AIDS
1995
Bronchoscopy-associated Mycobacterium xenopi pseudoinfections.
1994 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
2008
Interstitial lung disease guideline
2008
Nutritional status, ICU duration and ICU mortality in lung transplant recipients
1996
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Clinical and radiological features of Mycobacterium kansasii and other NTM infections
2012
Qualitative and Quantitative Drug-susceptibility Tests in Mycobacteriology
1988
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
2013 Standout
Circos: An information aesthetic for comparative genomics
2009 Standout
A 62-Dose, 6-Month Therapy for Pulmonary and Extrapulmonary Tuberculosis
1990
Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response
2004
The Impact of Nutritional Status on the Outcome of Lung Volume Reduction Surgery
1999
Mycobacterium xenopi Pneumonia in the Southeastern United States
2003
Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak
2001
Pulmonary Infection with Nontuberculous Mycobacteria
1988
Management of malignant pleural effusions
2001 Standout
Clinical Features and Metabolic and Autoimmune Derangements in Acquired Partial Lipodystrophy
2004
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Dietary Supplementation and Respiratory Muscle Performance in Patients with COPD
1988
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
2000
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov.
2006 Standout
Sclerotherapy for Malignant Pleural Effusions
1998
Bioelectrical impedance analysis?part I: review of principles and methods
2004 Standout
Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease
1999
Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
1990 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome
2000 Standout
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
1999 Standout
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease
2004
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
1998 Standout
Idiopathic Pulmonary Fibrosis
1998 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Impact of Nutritional Support on Functional Status During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
1997
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Nutritional Assessment and Support in Chronic Obstructive Pulmonary Disease
1990
Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
1987
Clinical review of pulmonary disease caused by Mycobacterium xenopi.
1983
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
1996
Diaphragmatic energy expenditure in chronic respiratory failure
1977 Standout
Short-Course Chemotherapy for Extrapulmonary Tuberculosis
1986
Serial computed tomographic evaluation in desquamative interstitial pneumonia
1997
Novel Diagnostic Algorithm for Identification of Mycobacteria Using Genus-Specific Amplification of the 16S-23S rRNA Gene Spacer and Restriction Endonucleases
2000 Standout
A review of the main bacterial fish diseases in mariculture systems
2005 Standout
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Nutritional supplementation in ambulatory patients with chronic obstructive pulmonary disease.
1987
Bronchoscopic Microsampling for Bacterial Colony Counting in Relevant Lesions in Patients with Pulmonary Mycobacterium avium Complex Infection
2011
Infections due to non-tuberculous mycobacteria (NTM).
2004
Epidemiology of infection by nontuberculous mycobacteria
1996
Clinical Characteristics and Treatment Outcomes ofMycobacterium kansasiiLung Disease in Korea
2010
Hodgkin's lymphoma
2003
Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis.
1996
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
1997 Standout
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
The Effect of Combined Therapy According to the Guidelines for the Treatment of Mycobacterium avium Complex Pulmonary Disease
2003
The Mycobacterium avium complex
1993
Yellow nail syndrome
1997
Works of A M Hunter being referenced
Partial lipodystrophy with nephrotic syndrome
1978
Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
1980
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.
1981
Management of extra-pulmonary tuberculosis (excluding miliary and meningeal) in south and west Wales (1976-8).
1982
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
1983
Survey of pulmonary tuberculosis in south and west Wales (1976-8).
1982
Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect.
2001
Pulmonary infection with mycobacterium xenopi: review of treatment and response.
1984
Yellow nail syndrome associated with empyema
1989
The nutritional status of patients with chronic obstructive pulmonary disease.
1981
Relapse of fibrosing alveolitis (desquamative interstitial pneumonia) after twelve years.
1979